Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ariad describes bone antiresorptive proteasome inhibitors and their use

Oct. 27, 2003

Spotlight on new drugs to treat female sexual dysfunction

Oct. 24, 2003

Spotlight on "diabesity"

Oct. 24, 2003

Encouraging preliminary phase II results for ThGRF in COPD wasting

Oct. 23, 2003

Topiramate improves body composition and blood pressure of obese patients

Oct. 23, 2003

Merck Frosst and AxyS patent describes new cathepsin K inhibitors

Oct. 23, 2003

Dual NO donors/antioxidants and their use in syndrome X and other disorders

Oct. 23, 2003

Spotlight on endometriosis

Oct. 23, 2003

Novel once-daily basal insulin cleared for marketing in Japan

Oct. 22, 2003

Global agreement reached by Roche and Ipsen for GLP-1 analogue

Oct. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...